Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Infectious Disease Diagnostics Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Infectious Disease Diagnostics Industry
  • 1.7 COVID-19 Impact: Infectious Disease Diagnostics Market Trends

    • 2 Global Infectious Disease Diagnostics Quarterly Market Size Analysis

    • 2.1 Infectious Disease Diagnostics Business Impact Assessment - COVID-19
      • 2.1.1 Global Infectious Disease Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Infectious Disease Diagnostics Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Infectious Disease Diagnostics Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Infectious Disease Diagnostics Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Infectious Disease Diagnostics Market
    • 3.4 Key Players Infectious Disease Diagnostics Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Infectious Disease Diagnostics Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Molecular Diagnostic Technique
      • 1.4.2 Traditional Diagnostic Technique
    • 4.2 By Type, Global Infectious Disease Diagnostics Market Size, 2019-2021

    5 Impact of Covid-19 on Infectious Disease Diagnostics Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hepatitis C
      • 5.5.2 Hepatitis B
      • 5.5.3 Tuberculosis (TB)
      • 5.5.4 Acquired Immunodeficiency Syndrome (AIDS)
      • 5.5.5 Human Papillomavirus (HPV)
      • 5.5.6 Methicillin-resistant Staphylococcus Aureus (MRSA)
    • 5.2 By Application, Global Infectious Disease Diagnostics Market Size, 2019-2021
      • 5.2.1 By Application, Global Infectious Disease Diagnostics Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Bio Mérieux SA
      • 7.1.1 Bio Mérieux SA Business Overview
      • 7.1.2 Bio Mérieux SA Infectious Disease Diagnostics Quarterly Revenue, 2020
      • 7.1.3 Bio Mérieux SA Infectious Disease Diagnostics Product Introduction
      • 7.1.4 Bio Mérieux SA Response to COVID-19 and Related Developments
    • 7.2 Roche Diagnostics
      • 7.2.1 Roche Diagnostics Business Overview
      • 7.2.2 Roche Diagnostics Infectious Disease Diagnostics Quarterly Revenue, 2020
      • 7.2.3 Roche Diagnostics Infectious Disease Diagnostics Product Introduction
      • 7.2.4 Roche Diagnostics Response to COVID-19 and Related Developments
    • 7.3 Abbott Laboratories
      • 7.3.1 Abbott Laboratories Business Overview
      • 7.3.2 Abbott Laboratories Infectious Disease Diagnostics Quarterly Revenue, 2020
      • 7.3.3 Abbott Laboratories Infectious Disease Diagnostics Product Introduction
      • 7.3.4 Abbott Laboratories Response to COVID-19 and Related Developments
    • 7.4 Thermo Fischer Scientific
      • 7.4.1 Thermo Fischer Scientific Business Overview
      • 7.4.2 Thermo Fischer Scientific Infectious Disease Diagnostics Quarterly Revenue, 2020
      • 7.4.3 Thermo Fischer Scientific Infectious Disease Diagnostics Product Introduction
      • 7.4.4 Thermo Fischer Scientific Response to COVID-19 and Related Developments
    • 7.5 BD
      • 7.5.1 BD Business Overview
      • 7.5.2 BD Infectious Disease Diagnostics Quarterly Revenue, 2020
      • 7.5.3 BD Infectious Disease Diagnostics Product Introduction
      • 7.5.4 BD Response to COVID-19 and Related Developments
    • 7.6 Bio-Rad Laboratories
      • 7.6.1 Bio-Rad Laboratories Business Overview
      • 7.6.2 Bio-Rad Laboratories Infectious Disease Diagnostics Quarterly Revenue, 2020
      • 7.6.3 Bio-Rad Laboratories Infectious Disease Diagnostics Product Introduction
      • 7.6.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
    • 7.7 Abbott
      • 7.7.1 Abbott Business Overview
      • 7.7.2 Abbott Infectious Disease Diagnostics Quarterly Revenue, 2020
      • 7.7.3 Abbott Infectious Disease Diagnostics Product Introduction
      • 7.7.4 Abbott Response to COVID-19 and Related Developments
    • 7.8 Danaher
      • 7.8.1 Danaher Business Overview
      • 7.8.2 Danaher Infectious Disease Diagnostics Quarterly Revenue, 2020
      • 7.8.3 Danaher Infectious Disease Diagnostics Product Introduction
      • 7.8.4 Danaher Response to COVID-19 and Related Developments
    • 7.9 Johnson and Johnson
      • 7.9.1 Johnson and Johnson Business Overview
      • 7.9.2 Johnson and Johnson Infectious Disease Diagnostics Quarterly Revenue, 2020
      • 7.9.3 Johnson and Johnson Infectious Disease Diagnostics Product Introduction
      • 7.9.4 Johnson and Johnson Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Infectious Disease Diagnostics, including the following market information:
      Global Infectious Disease Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Infectious Disease Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Infectious Disease Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Infectious Disease Diagnostics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Bio Mérieux SA, Roche Diagnostics, Abbott Laboratories, Thermo Fischer Scientific, BD, Bio-Rad Laboratories, Abbott, Danaher, Johnson and Johnson, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Molecular Diagnostic Technique
      Traditional Diagnostic Technique

      Based on the Application:
      Hepatitis C
      Hepatitis B
      Tuberculosis (TB)
      Acquired Immunodeficiency Syndrome (AIDS)
      Human Papillomavirus (HPV)
      Methicillin-resistant Staphylococcus Aureus (MRSA)

      Buy now